Skip to main content
Premium Trial:

Request an Annual Quote

IDbyDNA, ARUP Laboratories Partner to Develop, Commercialize NGS Infectious Disease Tests

NEW YORK (GenomeWeb) – IDbyDNA announced today its partnership with ARUP Laboratories to develop and commercialize next-generation-sequencing (NGS) infectious disease testing using metagenomics, aiming to yield results that are more comprehensive, sensitive, and accurate than current tests.

Conventional testing procedures are normally restricted to requesting specific pathogens and can return a high percentage of negative results, leaving clinicians without crucial information required to efficiently diagnose and treat their patients.

Using IDbyDNA clinical metagenomics software, ARUP's tests aim to deliver more comprehensive results with higher diagnostic yields and better accuracy compared to current tests. ARUP will offer the first test for pneumonia through its established clinical network in the coming weeks.

"[The partnership] is a perfect combination of ARUP's scientific and clinical laboratory expertise and IDbyDNA's expertise in metagenomics and data science" ARUP CEO Edgar Braendle said in a statement. "We are combining laboratory medicine with state-of-the-art genomics and computer science to bring precision medicine to infectious diseases." 

IDbyDNA's metagenomics software is powered by Taxonomer, a DNA analysis tool that rapidly detects microorganisms in clinical samples by their genetic material.

Using this approach to test for infectious disease, physicians can perform hypothesis-free diagnoses, meaning they will no longer have to guess the involvement of specific pathogens before ordering tests.

During development, IDbyDNA gained access to ARUP's high-complexity diagnostic testing experience and thousands of ARUP pathogenic validation samples.

"With ARUP's 3,000-plus clients across the US, we can rapidly bring state-of-the-art NGS metagenomic tests to more patients and can deliver clinicians significantly higher diagnostic yields and more actionable results than ever before" IDbyDNA CEO Guochun Liao said in a statement.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.